Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The duty to warn about transfusion risks.

D E Willett1

  • 1Hassard, Bonnington, Rogers, and Huber, San Francisco.

Archives of Pathology & Laboratory Medicine
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Legal aspects of blood transfusion.

The Journal of the Florida Medical Association·1993
Same author

How ADA (Americans with Disabilities Act) applies to the physician's office.

The Internist·1992
Same author

State access to peer review records: a clash of public policy.

The Medical staff counselor·1990
Same author

More on doctors' unions: are private practitioners "de facto employees"?

The New England journal of medicine·1985
Same author

The legal status of the medical staff.

Connecticut medicine·1984
Same author

PSRO today: a lawyer's assessment.

The New England journal of medicine·1975
Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026
Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
See all related articles

Blood banks face potential liability for transfusion-transmitted diseases. Medical directors should inform clinicians about transfusion risks and alternatives to ensure proper patient communication during informed consent.

Area of Science:

  • Transfusion Medicine
  • Medical Liability
  • Patient Safety

Background:

  • Patients contracting transfusion-transmitted diseases may sue blood banks and transfusion services.
  • Current legal precedent does not mandate informed consent duties for hospitals or blood banks.
  • Emerging legal theories may create new avenues for liability regarding transfusion risks.

Purpose of the Study:

  • To advise blood bank and transfusion service medical directors on potential legal liabilities.
  • To emphasize the importance of informing clinicians about transfusion risks and alternatives.
  • To promote effective patient communication during the informed consent process.

Main Methods:

  • Review of legal precedents concerning transfusion liability.
Keywords:
Legal ApproachProfessional Patient Relationship

Related Experiment Videos

  • Analysis of potential future legal claims and theories.
  • Recommendations for blood bank and transfusion service medical directors.

    • Main Results:

    • Physicians are responsible for informed consent regarding transfusion risks.
    • Blood banks and transfusion services currently lack a direct duty to warn patients.
    • Judicial decisions may evolve, creating new liability for transfusion services.

    Conclusions:

    • Blood bank and transfusion service medical directors must proactively manage risks.
    • Providing clinicians with comprehensive information on transfusion risks and alternatives is crucial.
    • Encouraging clear communication between clinicians and patients during informed consent is advised to mitigate potential legal challenges.